Last 12 months
Inside the activity.
0 purchase rows · 40 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 05, 2022 Filed Jul 7, 2022 22:26 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 1,990 | $28.70 | $57,113.00 |
DisclosureSEC source: 0001759655-22-000088 · wf-form4_165723279734220.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,401 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:26 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, $0.01 par value per share | 40,000 | $2.00 | $80,000.00 |
DisclosureSEC source: 0001759655-22-000088 · wf-form4_165723279734220.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 18:35 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 32 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000080 · wf-form4_165661413077757.xml · derivative · entry 3 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,141 Underlying: Common Stock · 32 shares Expires 2029-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 28,242 of the stock options are fully vested and exercisable. 6,438 of the stock options will vest on October 29, 2022, and 2,493 of the stock options will vest on December 4, 2022. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 18:35 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, $0.01 par value per share | 32 | $30.00 | $960.00 |
DisclosureSEC source: 0001759655-22-000080 · wf-form4_165661413077757.xml · nonDerivative · entry 2 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,104 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 18:35 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionCommon Stock, $0.01 par value per share | 32 | $2.00 | $64.00 |
DisclosureSEC source: 0001759655-22-000080 · wf-form4_165661413077757.xml · nonDerivative · entry 1 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 18:34 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 48 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000078 · wf-form4_165661402873837.xml · derivative · entry 3 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,252 Underlying: Common Stock · 48 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 300,198 of the stock options are fully vested and exercisable. 64,102 of the stock options will vest on October 29, 2022. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 18:34 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 48 | $30.00 | $1,440.00 |
DisclosureSEC source: 0001759655-22-000078 · wf-form4_165661402873837.xml · nonDerivative · entry 2 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,355 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 18:34 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.01 par value per share | 48 | $2.00 | $96.00 |
DisclosureSEC source: 0001759655-22-000078 · wf-form4_165661402873837.xml · nonDerivative · entry 1 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,403 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 18:03 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 77,534 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000074 · wf-form4_165609379939238.xml · derivative · entry 8 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,393,243 Underlying: Common Stock · 77,534 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 18:03 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 50,086 | $29.68 | $1,486,502.39 |
DisclosureSEC source: 0001759655-22-000074 · wf-form4_165609379939238.xml · nonDerivative · entry 6 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,739 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.32 to $29.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 18:03 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 27,448 | $28.93 | $793,933.40 |
DisclosureSEC source: 0001759655-22-000074 · wf-form4_165609379939238.xml · nonDerivative · entry 5 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,825 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.32 to $29.31 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 18:03 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock, $0.01 par value per share | 77,534 | $2.00 | $155,068.00 |
DisclosureSEC source: 0001759655-22-000074 · wf-form4_165609379939238.xml · nonDerivative · entry 4 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 18:03 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 69,843 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000074 · wf-form4_165609379939238.xml · derivative · entry 7 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,470,777 Underlying: Common Stock · 69,843 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 18:03 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 5,522 | $29.65 | $163,743.87 |
DisclosureSEC source: 0001759655-22-000074 · wf-form4_165609379939238.xml · nonDerivative · entry 3 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,739 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.54 to $29.88 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 18:03 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 64,321 | $29.12 | $1,873,091.84 |
DisclosureSEC source: 0001759655-22-000074 · wf-form4_165609379939238.xml · nonDerivative · entry 2 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,261 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.54 to $29.53 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 18:03 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock, $0.01 par value per share | 69,843 | $2.00 | $139,686.00 |
DisclosureSEC source: 0001759655-22-000074 · wf-form4_165609379939238.xml · nonDerivative · entry 1 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:08 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 60,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000071 · wf-form4_165601487061281.xml · derivative · entry 4 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,585,692 Underlying: Common Stock · 60,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:08 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 17,479 | $29.63 | $517,902.77 |
DisclosureSEC source: 0001759655-22-000071 · wf-form4_165601487061281.xml · nonDerivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.39 to $29.85 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:08 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 42,521 | $29.05 | $1,235,235.05 |
DisclosureSEC source: 0001759655-22-000071 · wf-form4_165601487061281.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,870 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.38 to $29.37 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:08 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, $0.01 par value per share | 60,000 | $2.00 | $120,000.00 |
DisclosureSEC source: 0001759655-22-000071 · wf-form4_165601487061281.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:09 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 10,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000072 · wf-form4_165601492485718.xml · derivative · entry 4 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,300 Underlying: Common Stock · 10,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:09 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 3,766 | $29.61 | $111,511.26 |
DisclosureSEC source: 0001759655-22-000072 · wf-form4_165601492485718.xml · nonDerivative · entry 3 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,355 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.38 to $29.84 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:09 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 6,234 | $29.01 | $180,848.34 |
DisclosureSEC source: 0001759655-22-000072 · wf-form4_165601492485718.xml · nonDerivative · entry 2 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,121 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.38 to $29.37 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:09 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.01 par value per share | 10,000 | $2.00 | $20,000.00 |
DisclosureSEC source: 0001759655-22-000072 · wf-form4_165601492485718.xml · nonDerivative · entry 1 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 18:57 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 10,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000068 · wf-form4_165471464651753.xml · derivative · entry 3 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,300 Underlying: Common Stock · 10,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 18:57 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 10,000 | $25.01 | $250,100.00 |
DisclosureSEC source: 0001759655-22-000068 · wf-form4_165471464651753.xml · nonDerivative · entry 2 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,355 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.06 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 18:57 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.01 par value per share | 10,000 | $2.00 | $20,000.00 |
DisclosureSEC source: 0001759655-22-000068 · wf-form4_165471464651753.xml · nonDerivative · entry 1 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 18:55 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 40,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000067 · wf-form4_165471451389961.xml · derivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,645,692 Underlying: Common Stock · 40,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 18:55 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 40,000 | $25.01 | $1,000,400.00 |
DisclosureSEC source: 0001759655-22-000067 · wf-form4_165471451389961.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.06 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 18:55 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, $0.01 par value per share | 40,000 | $2.00 | $80,000.00 |
DisclosureSEC source: 0001759655-22-000067 · wf-form4_165471451389961.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 20:29 UTC |
Bartrum ThomasEVP, General Counsel
|
GrantCommon Stock, $0.01 par value per share | 63,964 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020414 · doc4.xml · nonDerivative · entry 1 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,355 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will vest on the third anniversary of the grant date. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:32 UTC |
Ryu JaewonDirector
|
GrantCommon Stock, $0.01 par value per share | 7,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020422 · doc4.xml · nonDerivative · entry 1 Ryu Jaewon · CIK 0001869233 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,369 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:29 UTC |
Maryland Patricia AnneDirector
|
GrantCommon Stock, $0.01 par value per share | 7,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020416 · doc4.xml · nonDerivative · entry 1 Maryland Patricia Anne · CIK 0001798468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,034 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:33 UTC |
KING DAVID PDirector
|
GrantCommon Stock, $0.01 par value per share | 7,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020424 · doc4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,034 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:42 UTC |
McCarthy Thomas ADirector
|
GrantCommon Stock, $0.01 par value per share | 7,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020432 · doc4.xml · nonDerivative · entry 1 McCarthy Thomas A · CIK 0001500886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,729 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:32 UTC |
Sullivan William MDirector
|
GrantCommon Stock, $0.01 par value per share | 7,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020423 · doc4.xml · nonDerivative · entry 1 Sullivan William M · CIK 0001859839 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,034 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:30 UTC |
Butler Jeffrey BDirector
|
GrantCommon Stock, $0.01 par value per share | 7,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020417 · doc4.xml · nonDerivative · entry 1 Butler Jeffrey B · CIK 0001859428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,659,637 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| April 20, 2022 Filed Apr 22, 2022 16:31 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 20,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000054 · wf-form4_165064509268045.xml · derivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,685,692 Underlying: Common Stock · 20,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2022 Filed Apr 22, 2022 16:31 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 20,000 | $27.93 | $558,600.00 |
DisclosureSEC source: 0001759655-22-000054 · wf-form4_165064509268045.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.69 to $28.43 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| April 20, 2022 Filed Apr 22, 2022 16:31 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, $0.01 par value per share | 20,000 | $2.00 | $40,000.00 |
DisclosureSEC source: 0001759655-22-000054 · wf-form4_165064509268045.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2022 Filed Apr 22, 2022 13:18 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 10,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000052 · wf-form4_165063351163711.xml · derivative · entry 3 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,300 Underlying: Common Stock · 10,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2022 Filed Apr 22, 2022 13:18 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 10,000 | $27.93 | $279,300.00 |
DisclosureSEC source: 0001759655-22-000052 · wf-form4_165063351163711.xml · nonDerivative · entry 2 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.58 to $28.45 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| April 20, 2022 Filed Apr 22, 2022 13:18 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.01 par value per share | 10,000 | $2.00 | $20,000.00 |
DisclosureSEC source: 0001759655-22-000052 · wf-form4_165063351163711.xml · nonDerivative · entry 1 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:01 UTC |
Pamplona Capital Partners III, L.P.10% owner
Pamplona Equity Advisors III Ltd10% owner
Pamplona PE Investments Malta Ltd10% owner
Pamplona Capital Management, LLP10% owner
Pamplona Capital Management, LLC10% owner
Halsted John C.10% owner
Knaster Alexander M10% owner
|
OtherCommon Stock | 4,804,754 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905718-22-000542 · privia_fm4apr42022.xml · nonDerivative · entry 2 Pamplona Capital Partners III, L.P. · CIK 0001554914 · 10% owner Pamplona Equity Advisors III Ltd · CIK 0001859731 · 10% owner Pamplona Equity Carryco Advisors III, Ltd. · CIK 0001915350 · 10% owner Pamplona PE Investments Malta Ltd · CIK 0001650903 · 10% owner Pamplona Capital Management, LLP · CIK 0001554942 · 10% owner Pamplona Capital Management, LLC · CIK 0001554913 · 10% owner Halsted John C. · CIK 0001844403 · 10% owner Knaster Alexander M · CIK 0001308574 · 10% owner Pamplona Private Equity Carryco III, L.P. · CIK 0001915347 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 20,019,808 F2 · kind: Represents a cross-trade, pursuant to which PCP III transferred 4,804,754 shares of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. to PPEC for no monetary consideration. F2 · price: Represents a cross-trade, pursuant to which PCP III transferred 4,804,754 shares of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. to PPEC for no monetary consideration. F1 · ownership.nature: This statement is being filed by (i) Pamplona Capital Partners III, L.P. ("PCP III") (ii) Pamplona Equity Advisors III Ltd., (iii) Pamplona Private Equity Carryco III, L.P. ("PPEC"), (iv) Pamplona Equity Carryco III, Ltd., (v) Pamplona PE Investments Malta Limited, (vi) Pamplona Capital Management LLP, (vii) Pamplona Capital Management LLC, (viii) John C. Halsted and (ix) Alexander Knaster (the foregoing, collectively, the "Reporting Persons"). F3 · ownership.nature: The shares of Common Stock are held by PCP III and PPEC. PCP III is controlled by Pamplona Equity Advisors III Ltd., its general partner. John C. Halsted owns 100% of the shares of Pamplona Equity Advisors III, Ltd. Pamplona PE Investments Malta Limited serves as an investment manager to PCP III. Pamplona Capital Management LLP and Pamplona Capital Management LLC (together, the "Pamplona Manager Entities") serve as investment advisors to Pamplona PE Investments Malta Limited. Mr. John C. Halsted and Mr. Alexander Knaster are the principals of the Pamplona Manager Entities. PPEC is controlled by Pamplona Equity Carryco III, Ltd., its general partner. Mr. Alexander Knaster owns 100% of the shares of Pamplona Equity Carryco III, Ltd. F4 · ownership.nature: Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such person or entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:01 UTC |
Pamplona Capital Partners III, L.P.10% owner
Pamplona Equity Advisors III Ltd10% owner
Pamplona PE Investments Malta Ltd10% owner
Pamplona Capital Management, LLP10% owner
Pamplona Capital Management, LLC10% owner
Halsted John C.10% owner
Knaster Alexander M10% owner
|
OtherCommon Stock | 4,804,754 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905718-22-000542 · privia_fm4apr42022.xml · nonDerivative · entry 1 Pamplona Capital Partners III, L.P. · CIK 0001554914 · 10% owner Pamplona Equity Advisors III Ltd · CIK 0001859731 · 10% owner Pamplona Equity Carryco Advisors III, Ltd. · CIK 0001915350 · 10% owner Pamplona PE Investments Malta Ltd · CIK 0001650903 · 10% owner Pamplona Capital Management, LLP · CIK 0001554942 · 10% owner Pamplona Capital Management, LLC · CIK 0001554913 · 10% owner Halsted John C. · CIK 0001844403 · 10% owner Knaster Alexander M · CIK 0001308574 · 10% owner Pamplona Private Equity Carryco III, L.P. · CIK 0001915347 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 15,215,054 F2 · kind: Represents a cross-trade, pursuant to which PCP III transferred 4,804,754 shares of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. to PPEC for no monetary consideration. F2 · price: Represents a cross-trade, pursuant to which PCP III transferred 4,804,754 shares of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. to PPEC for no monetary consideration. F1 · ownership.nature: This statement is being filed by (i) Pamplona Capital Partners III, L.P. ("PCP III") (ii) Pamplona Equity Advisors III Ltd., (iii) Pamplona Private Equity Carryco III, L.P. ("PPEC"), (iv) Pamplona Equity Carryco III, Ltd., (v) Pamplona PE Investments Malta Limited, (vi) Pamplona Capital Management LLP, (vii) Pamplona Capital Management LLC, (viii) John C. Halsted and (ix) Alexander Knaster (the foregoing, collectively, the "Reporting Persons"). F3 · ownership.nature: The shares of Common Stock are held by PCP III and PPEC. PCP III is controlled by Pamplona Equity Advisors III Ltd., its general partner. John C. Halsted owns 100% of the shares of Pamplona Equity Advisors III, Ltd. Pamplona PE Investments Malta Limited serves as an investment manager to PCP III. Pamplona Capital Management LLP and Pamplona Capital Management LLC (together, the "Pamplona Manager Entities") serve as investment advisors to Pamplona PE Investments Malta Limited. Mr. John C. Halsted and Mr. Alexander Knaster are the principals of the Pamplona Manager Entities. PPEC is controlled by Pamplona Equity Carryco III, Ltd., its general partner. Mr. Alexander Knaster owns 100% of the shares of Pamplona Equity Carryco III, Ltd. F4 · ownership.nature: Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such person or entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| April 04, 2022 Filed Apr 29, 2022 20:32 UTC Amendment |
Pamplona Capital Partners III, L.P.10% owner
Pamplona Equity Advisors III Ltd10% owner
Pamplona PE Investments II, Ltd.10% owner
Pamplona PE Investments Malta Ltd10% owner
Pamplona Capital Management, LLP10% owner
Pamplona Capital Management, LLC10% owner
Halsted John C.10% owner
Knaster Alexander M10% owner
|
OtherCommon Stock | 4,804,754 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-22-011579 · ownership.xml · nonDerivative · entry 2 Pamplona Capital Partners III, L.P. · CIK 0001554914 · 10% owner Pamplona Equity Advisors III Ltd · CIK 0001859731 · 10% owner Pamplona Private Equity Carryco III, L.P. · CIK 0001915347 · 10% owner Pamplona Equity Carryco Advisors III, Ltd. · CIK 0001915350 · 10% owner Pamplona PE Investments II, Ltd. · CIK 0001915345 · 10% owner Pamplona PE Investments Malta Ltd · CIK 0001650903 · 10% owner Pamplona Capital Management, LLP · CIK 0001554942 · 10% owner Pamplona Capital Management, LLC · CIK 0001554913 · 10% owner Halsted John C. · CIK 0001844403 · 10% owner Knaster Alexander M · CIK 0001308574 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 20,019,808 F2 · kind: Represents a cross-trade, pursuant to which PCP III transferred 4,804,754 shares of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. to PPEC for no monetary consideration. F2 · price: Represents a cross-trade, pursuant to which PCP III transferred 4,804,754 shares of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. to PPEC for no monetary consideration. F1 · ownership.nature: This statement is being filed by (i) Pamplona Capital Partners III, L.P. ("PCP III") (ii) Pamplona Equity Advisors III Ltd., (iii) Pamplona Private Equity Carryco III, L.P. ("PPEC"), (iv) Pamplona Equity Carryco Advisors III, Ltd., (v) Pamplona PE Investments II, Ltd., (vi) Pamplona PE Investments Malta Limited, (vii) Pamplona Capital Management LLP, (viii) Pamplona Capital Management LLC, (ix) John C. Halsted and (x) Alexander M. Knaster (the foregoing, collectively, the "Reporting Persons"). F3 · ownership.nature: The shares of Common Stock are held by PCP III and PPEC. PCP III is controlled by Pamplona Equity Advisors III Ltd., its general partner. John C. Halsted owns 100% of the shares of Pamplona Equity Advisors III, Ltd. Pamplona PE Investments Malta Limited serves as an investment manager to PCP III. Pamplona Capital Management LLP and Pamplona Capital Management LLC (together, the "Pamplona Manager Entities") serve as investment advisors to Pamplona PE Investments Malta Limited. Mr. John C. Halsted and Mr. Alexander M. Knaster are the principals of the Pamplona Manager Entities. PPEC is controlled by Pamplona Equity Carryco Advisors III, Ltd., its general partner. Pamplona PE Investments II, Ltd. owns 100% of the shares of Pamplona Equity Carryco Advisors III, Ltd. Mr. Alexander M. Knaster owns 100% of the shares of Pamplona PE Investments II, Ltd. F4 · ownership.nature: Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such person or entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| April 04, 2022 Filed Apr 29, 2022 20:32 UTC Amendment |
Pamplona Capital Partners III, L.P.10% owner
Pamplona Equity Advisors III Ltd10% owner
Pamplona PE Investments II, Ltd.10% owner
Pamplona PE Investments Malta Ltd10% owner
Pamplona Capital Management, LLP10% owner
Pamplona Capital Management, LLC10% owner
Halsted John C.10% owner
Knaster Alexander M10% owner
|
OtherCommon Stock | 4,804,754 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-22-011579 · ownership.xml · nonDerivative · entry 1 Pamplona Capital Partners III, L.P. · CIK 0001554914 · 10% owner Pamplona Equity Advisors III Ltd · CIK 0001859731 · 10% owner Pamplona Private Equity Carryco III, L.P. · CIK 0001915347 · 10% owner Pamplona Equity Carryco Advisors III, Ltd. · CIK 0001915350 · 10% owner Pamplona PE Investments II, Ltd. · CIK 0001915345 · 10% owner Pamplona PE Investments Malta Ltd · CIK 0001650903 · 10% owner Pamplona Capital Management, LLP · CIK 0001554942 · 10% owner Pamplona Capital Management, LLC · CIK 0001554913 · 10% owner Halsted John C. · CIK 0001844403 · 10% owner Knaster Alexander M · CIK 0001308574 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 15,215,054 F2 · kind: Represents a cross-trade, pursuant to which PCP III transferred 4,804,754 shares of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. to PPEC for no monetary consideration. F2 · price: Represents a cross-trade, pursuant to which PCP III transferred 4,804,754 shares of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. to PPEC for no monetary consideration. F1 · ownership.nature: This statement is being filed by (i) Pamplona Capital Partners III, L.P. ("PCP III") (ii) Pamplona Equity Advisors III Ltd., (iii) Pamplona Private Equity Carryco III, L.P. ("PPEC"), (iv) Pamplona Equity Carryco Advisors III, Ltd., (v) Pamplona PE Investments II, Ltd., (vi) Pamplona PE Investments Malta Limited, (vii) Pamplona Capital Management LLP, (viii) Pamplona Capital Management LLC, (ix) John C. Halsted and (x) Alexander M. Knaster (the foregoing, collectively, the "Reporting Persons"). F3 · ownership.nature: The shares of Common Stock are held by PCP III and PPEC. PCP III is controlled by Pamplona Equity Advisors III Ltd., its general partner. John C. Halsted owns 100% of the shares of Pamplona Equity Advisors III, Ltd. Pamplona PE Investments Malta Limited serves as an investment manager to PCP III. Pamplona Capital Management LLP and Pamplona Capital Management LLC (together, the "Pamplona Manager Entities") serve as investment advisors to Pamplona PE Investments Malta Limited. Mr. John C. Halsted and Mr. Alexander M. Knaster are the principals of the Pamplona Manager Entities. PPEC is controlled by Pamplona Equity Carryco Advisors III, Ltd., its general partner. Pamplona PE Investments II, Ltd. owns 100% of the shares of Pamplona Equity Carryco Advisors III, Ltd. Mr. Alexander M. Knaster owns 100% of the shares of Pamplona PE Investments II, Ltd. F4 · ownership.nature: Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such person or entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 12:49 UTC |
COCOZZA NANCY GDirector
|
GrantCommon Stock, $0.01 par value per share | 7,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000048 · wf-form4_164916296106704.xml · nonDerivative · entry 1 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,073 F1 · security: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 12:53 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
GrantStock Option (Right to Purchase) · Derivative | 64,882 | $0.00 Strike: $26.73 | $0.00 |
DisclosureSEC source: 0001759655-22-000050 · wf-form4_164916320399046.xml · derivative · entry 2 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,882 Underlying: Common Stock · 64,882 shares Expires 2032-04-01 F2 · derivative.exercise_date: On April 1, 2022, the reporting person received 64,882 stock options under the Issuer's 2021 Omnibus Incentive Plan. The stock options will vest in substantially equal annual installments on the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 12:53 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
GrantCommon Stock, $0.01 par value per share | 48,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000050 · wf-form4_164916320399046.xml · nonDerivative · entry 1 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,104 F1 · shares: On April 1, 2022, the reporting person received 48,833 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest in substantially equal annual installments on the first, second, third and fourth anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.